An open-label, nonrandomized, single-center, prospective extension, clinical trial of booster dose schedules to assess the safety profile and immunogenicity of recombinant outer-surface protein A (OspA) Lyme disease vaccine.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples